Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long‐term survivors of type 1 diabetes: A Dialong substudy

Abstract Aims/Introduction The shortening of leukocyte telomere length with age has been associated with coronary disease, whereas the association with type 1 diabetes is unclear. We aimed to explore telomere lengths in diabetes patients with regard to coronary artery disease, compared with healthy...

Full description

Bibliographic Details
Main Authors: Trine Baur Opstad, Tore Julsrud Berg, Kristine Bech Holte, Harald Arnesen, Svein Solheim, Ingebjørg Seljeflot
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Journal of Diabetes Investigation
Subjects:
Online Access:https://doi.org/10.1111/jdi.13470
id doaj-eee68eb160664a11b81cd74a57b14ad2
record_format Article
spelling doaj-eee68eb160664a11b81cd74a57b14ad22021-07-08T07:31:25ZengWileyJournal of Diabetes Investigation2040-11162040-11242021-07-011271183119210.1111/jdi.13470Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long‐term survivors of type 1 diabetes: A Dialong substudyTrine Baur Opstad0Tore Julsrud Berg1Kristine Bech Holte2Harald Arnesen3Svein Solheim4Ingebjørg Seljeflot5Department of Cardiology Center for Clinical Heart Research Oslo University Hospital Ullevål NorwayFaculty of Medicine Institute of Clinical Medicine University of Oslo Oslo NorwayFaculty of Medicine Institute of Clinical Medicine University of Oslo Oslo NorwayDepartment of Cardiology Center for Clinical Heart Research Oslo University Hospital Ullevål NorwayDepartment of Cardiology Center for Clinical Heart Research Oslo University Hospital Ullevål NorwayDepartment of Cardiology Center for Clinical Heart Research Oslo University Hospital Ullevål NorwayAbstract Aims/Introduction The shortening of leukocyte telomere length with age has been associated with coronary disease, whereas the association with type 1 diabetes is unclear. We aimed to explore telomere lengths in diabetes patients with regard to coronary artery disease, compared with healthy controls. The longevity factors sirtuin 1 and growth‐differentiating factor 11 were investigated accordingly. Materials and Methods We carried out a cross‐sectional study of 102 participants with long‐term type 1 diabetes and 75 controls (mean age 62 and 63 years, respectively), where 88 cases and 60 controls without diagnosed coronary artery disease completed computed tomography coronary angiography. Telomere lengths and gene expression of sirtuin 1 and growth‐differentiating factor 11 were quantified in leukocytes. Results Telomere lengths and sirtuin 1 were reduced in diabetes patients versus controls, medians (25th to 75th percentiles): 0.97 (0.82–1.15) versus 1.08 (0.85–1.29) and 0.88 (0.65–1.14) vs 1.01 (0.78–1.36), respectively, adjusted P < 0.05, both. Previous coronary artery disease in diabetes patients (n = 15) was associated with lower sirtuin 1 and growth‐differentiating factor 11 messenger ribonucleic acid expression (adjusted P < 0.03, both). In the combined diabetes and control group, previous artery coronary disease (n = 18) presented with significantly shorter telomeres (adjusted P = 0.038). Newly diagnosed obstructive coronary artery disease, defined as >50% stenosis, was not associated with the investigated variables. Conclusions Long‐term type 1 diabetes presented with reduced telomeres and sirtuin 1 expression, with additional reduction in diabetes patients with previous coronary artery disease, showing their importance for cardiovascular disease development with potential as novel biomarkers in diabetes and coronary artery disease.https://doi.org/10.1111/jdi.13470Coronary diseaseDiabetes mellitus type 1Leukocyte telomere length
collection DOAJ
language English
format Article
sources DOAJ
author Trine Baur Opstad
Tore Julsrud Berg
Kristine Bech Holte
Harald Arnesen
Svein Solheim
Ingebjørg Seljeflot
spellingShingle Trine Baur Opstad
Tore Julsrud Berg
Kristine Bech Holte
Harald Arnesen
Svein Solheim
Ingebjørg Seljeflot
Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long‐term survivors of type 1 diabetes: A Dialong substudy
Journal of Diabetes Investigation
Coronary disease
Diabetes mellitus type 1
Leukocyte telomere length
author_facet Trine Baur Opstad
Tore Julsrud Berg
Kristine Bech Holte
Harald Arnesen
Svein Solheim
Ingebjørg Seljeflot
author_sort Trine Baur Opstad
title Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long‐term survivors of type 1 diabetes: A Dialong substudy
title_short Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long‐term survivors of type 1 diabetes: A Dialong substudy
title_full Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long‐term survivors of type 1 diabetes: A Dialong substudy
title_fullStr Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long‐term survivors of type 1 diabetes: A Dialong substudy
title_full_unstemmed Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long‐term survivors of type 1 diabetes: A Dialong substudy
title_sort reduced leukocyte telomere lengths and sirtuin 1 gene expression in long‐term survivors of type 1 diabetes: a dialong substudy
publisher Wiley
series Journal of Diabetes Investigation
issn 2040-1116
2040-1124
publishDate 2021-07-01
description Abstract Aims/Introduction The shortening of leukocyte telomere length with age has been associated with coronary disease, whereas the association with type 1 diabetes is unclear. We aimed to explore telomere lengths in diabetes patients with regard to coronary artery disease, compared with healthy controls. The longevity factors sirtuin 1 and growth‐differentiating factor 11 were investigated accordingly. Materials and Methods We carried out a cross‐sectional study of 102 participants with long‐term type 1 diabetes and 75 controls (mean age 62 and 63 years, respectively), where 88 cases and 60 controls without diagnosed coronary artery disease completed computed tomography coronary angiography. Telomere lengths and gene expression of sirtuin 1 and growth‐differentiating factor 11 were quantified in leukocytes. Results Telomere lengths and sirtuin 1 were reduced in diabetes patients versus controls, medians (25th to 75th percentiles): 0.97 (0.82–1.15) versus 1.08 (0.85–1.29) and 0.88 (0.65–1.14) vs 1.01 (0.78–1.36), respectively, adjusted P < 0.05, both. Previous coronary artery disease in diabetes patients (n = 15) was associated with lower sirtuin 1 and growth‐differentiating factor 11 messenger ribonucleic acid expression (adjusted P < 0.03, both). In the combined diabetes and control group, previous artery coronary disease (n = 18) presented with significantly shorter telomeres (adjusted P = 0.038). Newly diagnosed obstructive coronary artery disease, defined as >50% stenosis, was not associated with the investigated variables. Conclusions Long‐term type 1 diabetes presented with reduced telomeres and sirtuin 1 expression, with additional reduction in diabetes patients with previous coronary artery disease, showing their importance for cardiovascular disease development with potential as novel biomarkers in diabetes and coronary artery disease.
topic Coronary disease
Diabetes mellitus type 1
Leukocyte telomere length
url https://doi.org/10.1111/jdi.13470
work_keys_str_mv AT trinebauropstad reducedleukocytetelomerelengthsandsirtuin1geneexpressioninlongtermsurvivorsoftype1diabetesadialongsubstudy
AT torejulsrudberg reducedleukocytetelomerelengthsandsirtuin1geneexpressioninlongtermsurvivorsoftype1diabetesadialongsubstudy
AT kristinebechholte reducedleukocytetelomerelengthsandsirtuin1geneexpressioninlongtermsurvivorsoftype1diabetesadialongsubstudy
AT haraldarnesen reducedleukocytetelomerelengthsandsirtuin1geneexpressioninlongtermsurvivorsoftype1diabetesadialongsubstudy
AT sveinsolheim reducedleukocytetelomerelengthsandsirtuin1geneexpressioninlongtermsurvivorsoftype1diabetesadialongsubstudy
AT ingebjørgseljeflot reducedleukocytetelomerelengthsandsirtuin1geneexpressioninlongtermsurvivorsoftype1diabetesadialongsubstudy
_version_ 1721313729149140992